Halozyme Therapeutics, Inc. Stock Performance

Open $109.50	Prev. Close $110.90	Circuit Range N/A
Day Range $107.47 - $110.64	Year Range $61.24 - $116.57	Volume 1,19,850
Average Traded $109.36

Halozyme Therapeutics, Inc. Share Price Today

As of 9 October 2026, Halozyme Therapeutics, Inc.'s share price is $109.88. The stock opened at $109.50, compared to its previous close of $110.90. During today's trading session, Halozyme Therapeutics, Inc.'s share price traded between $107.47 and $110.64, with an average price of $109.06. Over the past 52 weeks, the stock has recorded a high of $116.57 and a low of $61.24. In terms of performance, Halozyme Therapeutics, Inc.'s share price has risen by 72.63% over the last six months and is up 68.63% on a year-on-year basis.

Halozyme Therapeutics, Inc. Share Price Chart

$107.47$110.64

Halozyme Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap $13.17B	PE Ratio (TTM) 30.14	Dividend Yield 0.00%
EPS (TTM) $3.64	Revenue (TTM) $1.40T	Return On Equity (TTM) 288.13%
Profit Margin 22.69%	Debt to Equity 14.95	Quarterly Earnings Growth YoY 31.20%

Halozyme Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

Particulars	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	$354.26	$451.77	$376.71	$481.00
Net Profit	$175.23	-$141.59	$150.05	$229.91
Net Profit Margin	49.46%	-31.34%	39.83%	47.80%
Income Change	N/A	-180.80%	205.97%	53.22%

Halozyme Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars	2022	2023	2024	2025
Revenue	$660.12	$829.25	$1015.32	$1396.61
Net Profit	$202.13	$281.59	$444.09	$316.89
Net Profit Margin	30.62%	33.96%	43.74%	22.69%
Income Change	N/A	39.31%	57.71%	-28.64%

About Halozyme Therapeutics, Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Halozyme Therapeutics, Inc. Historical Returns

Month	Open	Close	Change %
Oct 2026	$109.57	$109.83	-0.63%
Sep 2026	$107.94	$110.52	+3.37%
Aug 2026	$82.42	$106.92	+29.55%
Jul 2026	$78.42	$82.53	+5.53%
Jun 2026	$66.10	$78.21	+17.52%
May 2026	$63.41	$66.55	+4.56%
Apr 2026	$64.74	$63.65	-1.49%
Mar 2026	$69.05	$64.61	-7.09%
Feb 2026	$71.64	$69.55	-2.91%
Jan 2026	$67.73	$71.63	+6.47%
Dec 2025	$71.77	$67.28	-5.86%
Nov 2025	$65.45	$71.47	+9.68%

HALO Share Price FAQs

What is Halozyme Therapeutics, Inc. share price today?

Halozyme Therapeutics, Inc. share price today is $109.88 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Halozyme Therapeutics, Inc. stock?

The 52 week high of Halozyme Therapeutics, Inc. stock is $116.57, while the 52 week low is $61.24 as of 9 Oct '26.

What is HALO's market capitalisation today?

HALO market capitalisation is $13.17B as of October 9, 2026, at 6:12 pm IST.

What is HALO's net income for the last quarter?

HALO's net income for the last quarter is 229.91B USD.

What is the 5 year returns of HALO?

The 5 year returns of HALO is 188.63% as on 9 Oct '26.

What is the high & low stock price of HALO today?

HALO stock price hit a high of $110.64 and low of $107.47 as of 9 Oct '26.

Can I buy HALO shares in India?

Yes. You can buy HALO in India by opening an international trading account.